New Approach From Real World Evidence To Reduce Residual Risk In Cardiometabolic Disease

14 Aug 2021 14:00 14:50
Sponsored by Abbott Pharmaceuticals
Dr Ma Soot Keng Speaker
Dr Kisheaan Devarajan Chairperson

You can view the video ONLY if you are logged in. Click here to login

Nothing to display here